is retatrutide glp 1 Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Beyond GLP-1: Retatrutide's triple-agonist mechanism

the same would apply to a woman using a combined oral preparation, as any reduction in efficacy would apply equally to the oestrogen and the progestogen and so not increase the risk of endometrial proliferation

3-Year Shelf Life: Ensures product stability and efficacy for up to 3 years when stored properly

If their provider believes that a GLP-1 weight management medication may improve their health outcomes, they can collaborate with a compounding pharmacy to customize one that fits the patient's health preferences

This finding holds particular importance given no medications currently target both alcohol reduction and smoking cessation simultaneously